Cantor Fitzgerald’s Post

During our recent Biotech Panel moderated by Eric Schmidt, four specialist fund managers shared their insights on exciting themes in the biotech sector. Here are some key takeaways: To learn more about Cantor’s insights on biotech or future events hosted by Cantor’s Prime and Capital Introduction team, please reach out to us: https://lnkd.in/eB6TnVmE.

Cantor Prime Services is capturing the attention of smaller hedge funds often overlooked by major banks. Our enhanced European offering has plans to expand its capabilities, providing tailored, cost-effective solutions for smaller funds. Read what Sean Capstick, Chief Executive Officer and Head of Prime Brokerage at Cantor Fitzgerald Europe, had to say in Hedgeweek. Interested in learning more about Cantor Prime Services? Reach out to us here: https://lnkd.in/eB6TnVmE

Last week, Cantor's Capital Introduction team hosted its inaugural Biotech Panel, moderated by Senior Managing Director and Senior Biotechnology Analyst, Eric Schmidt, Ph.D. Panelists shared their insights on the latest trends and future directions in biotechnology, discussing groundbreaking therapies, diagnostics, and innovative solutions driving the sector forward. A special thank you to our panelists for their invaluable contributions to the success of this event: Anna Cosslett Yaeger, Partner & Head of Public Equities of 5AM Ventures; Vincent Aita, CIO & Managing Partner of Cutter Capital Management, LP; Kevin Pyun, CIO of Dellora Investments; and Rod Wong, CIO & Managing Partner of RTW Investments, LP. If you missed the panel or are interested in learning more about Cantor Prime Services and our Capital Introduction capabilities, please reach out to us here: https://lnkd.in/eB6TnVmE.

The semiconductor industry is primed for an elongated cycle, with the next peak likely in 2026. Cantor's CJ Muse, Senior Managing Director, Semiconductors and Semiconductor Equipment, explores the key trends and technologies fueling semiconductor demand. #CantorCalls #AI #MarketResearch #Semiconductors   

Biopharma's hot topic - weight loss drugs – will take center stage when Cantor’s Louise Chen speaks at the Seeking Alpha Investing Summit on June 18, 2024. Register below to attend and learn about how the GLP-1 drug market is anticipated to become the best-selling drug class in 2024. https://ow.ly/YW4P50SiQ4u

Companies that develop treatments for rare diseases are able to drive real value, despite a prior view that they were low market opportunities. Our research analyst, Kristen Kluska, unpacks how our research team uncovers the true impact of these companies. #CantorCalls #MarketResearch #RareDiseases

The eVTOL industry is poised to continue its path towards commercialization, as the US government reauthorizes the FAA and allocates funding. Learn what expert, Andres Sheppard, is taking away from the development. #eVTOLS #TechInvesting #MarketResearch #Innovation #Sustainability #Mobility  

From streamlining the deal process to making companies appear attractive for acquisition, Cantor’s Managing Director in Technology Investment Banking Mark Baillie discusses how #GenAI will impact M&A and raising capital.

Cantor’s Managing Director and Global Head of Technology Investment Banking Cole Bader shared advice on managing financing risk during a deal on the “Dynamics and Consideration in Today’s M&A Environment” panel at our Private Software Company Conference, in partnership with DLA Piper, earlier this week in Austin, TX. To learn more about how Cantor can help manage financing risk, visit https://lnkd.in/emQrt5za.